Please ensure Javascript is enabled for purposes of website accessibility

Aurora Cannabis Up on Encouraging Q4 Preliminary Results

By Eric Volkman – Aug 6, 2019 at 4:12PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company estimates that it will post significant top-line growth for the quarter.

Aurora Cannabis (ACB 4.31%), one of the most popular marijuana stocks on the market, today released preliminary, unaudited revenue figures for the company's fourth quarter of fiscal 2019, which concluded at the end of June. These numbers indicate that net revenue for the quarter landed between CA$100 million and CA$107 million (all figures in this story are in Canadian dollars).

Of this, the company estimates that CA$90 million to CA$95 million came from cannabis sales.

Marijuana growing in a facility.

Image source: Getty Images.

If realized, that top line would represent a substantial improvement over not only the same quarter of 2018 but also the company's Q3. In the former period, it took in revenue of just over CA$19 million. Aurora's Q3 net revenue was slightly more than CA$65 million. The robust anticipated growth is attributed to higher take in all of the company's key business segments, as well as in its domestic (Canada) and international markets.

That said, the CA$100 million to CA$107 million range is lower than the average analyst estimate of CA$114 million.

In terms of product, Aurora anticipates that its production available for sale in Q4 will hit the upper end of the 25,000-to-30,000 kilo range. It had previously estimated 25,000 kilos. In Q3, the company's production amounted to 15,590 kilos, and it sold 9,160 kilos.

For the entirety of fiscal 2019, Aurora believes it will post net revenue of CA$249 million to $256 million.

Aurora did not provide specific figures or ranges for profitability. It did state that it "continues to track toward positive adjusted EBITDA, and in particular adjusted EBITDA from cannabis operations." In Q3, the company posted a net loss of more than CA$158 million. This was an improvement over the preceding quarter, but it was deeper than both the average analyst estimate and the Q3 2018 shortfall of CA$19 million.

The company said it will provide official Q4 and full-year fiscal 2019 results before Sept. 15.

Investors are clearly encouraged by those numbers and the sharp growth they indicate, even though they could very well fall short of analyst projections. Aurora stock is up by 9% in late trading today.

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Aurora Cannabis Stock Quote
Aurora Cannabis
$1.21 (4.31%) $0.05

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/28/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.